Comparative value of solanaceous alkaloids in treatment of Parkinson's syndrome

[1] BREMER FW, 1925, ARCH KLIN MED, V149, P340

[2] CHOPRA RN, 1933, ART PRESS, P128

[3] CUSHNY AR, 1940, PHARMACOL THERAPEUT, P502

[4] FELSENMEIER H, 1935, MUNCHEN MED WCHNSCHR, V82, P1723

[5] LANGENHAN HA, 1914, ALKALOIDAL CONTENT S, V4

[6] NEAL JB, 1940, NEW YORK STATE J MED, V40, P1300

[7] PANEGROSSI G, 1935, POLICLINICO, V42, P56

[8] Price J, 1941, JAMA-J AM MED ASSOC, V117, P335

[9] ROEMER C, 1930, MUNCHEN MED WCHNSCHR, V77, P2156

[10] SIEGMUND H, 1935, MMW, V82, P453

[1] BREMER FW, 1925, ARCH KLIN MED, V149, P340

[2] CHOPRA RN, 1933, ART PRESS, P128

[3] CUSHNY AR, 1940, PHARMACOL THERAPEUT, P502

[4] FELSENMEIER H, 1935, MUNCHEN MED WCHNSCHR, V82, P1723

[5] LANGENHAN HA, 1914, ALKALOIDAL CONTENT S, V4

[6] NEAL JB, 1940, NEW YORK STATE J MED, V40, P1300

[7] PANEGROSSI G, 1935, POLICLINICO, V42, P56

[8] Price J, 1941, JAMA-J AM MED ASSOC, V117, P335

[9] ROEMER C, 1930, MUNCHEN MED WCHNSCHR, V77, P2156

[10] SIEGMUND H, 1935, MMW, V82, P453